InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank43
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-7.92M
Near historical average
Percentile
P43
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-8.20M
Historical baseline
PeriodValueYoY Change
2025$-7.92M+2.7%
2024$-8.13M+2.9%
2023$-8.38M+39.2%
2022$-13.79M-13.3%
2021$-12.17M-33.0%
2020$-9.15M+11.7%
2019$-10.36M-52.8%
2018$-6.78M-97.1%
2017$-3.44M-87.2%
2016$-1.84M-